One of the first questions we ask any medtech founder is: what problem is your technology solving?
If the answer is about how cool and innovative the technology is, and how it will revolutionise a particular space — you probably need to spend more time inside the hospital and OT.
That's not a criticism. It's a pattern we see constantly. Founders who have spent years perfecting a technology naturally see the world through it. The innovation is ready. The clinical need is obvious to them. What could possibly go wrong?
Quite a lot, as it turns out.
The technology being ready and the market being ready are two very different things.
Platform innovation vs. patient-centric innovation
There's a distinction that doesn't get talked about enough in medtech: the difference between platform-based innovation and patient-centric innovation.
Platform-based innovation starts with the technology. You've built something genuinely new — and now you're looking for the clinical problem it solves. Patient-centric innovation starts the other way around. It begins with a specific patient pathway and works backwards.
Which therapeutic area? Which modality? Where in the patient value chain does your solution create real value — for the patient, the HCP, the provider? These questions sound straightforward. They are not.
And getting them wrong is expensive. We've seen founding teams lose six or seven years commercialising in the wrong modality — building a product that solves a problem, but not a significant enough problem. After multiple pivots, product iterations, and enormous grit, they eventually find the patient pathway where their technology truly makes a difference. By then, a lot of runway is gone.
The question that actually matters
Once your fit is clear, the real test is simple: is your solution significant enough that someone will pay for it consistently?
Not in a pilot. Not because a friendly clinician agreed to try it. Consistently. At a price that works. At a volume that creates real impact.
That's a harder bar than most founders expect. And it's the right bar.
Is your solution significant enough that someone will pay for it consistently? That's the question that needs to be answered.
How to evaluate your fit
Product-market fit in medtech is never a single moment of validation. It's multi-layered, and every layer needs to be evaluated on its own terms.
Start with the patient pathway — the specific journey from symptom to treatment, and the exact point where your technology intervenes. The more precisely you can map this, the more honest your fit assessment will be.
Then work through your stakeholders. Provider, payor, patient, HCP — and in some cases the policy maker. Each one has a different lens. Each one has to say yes in their own way.
And through all of this, keep the four dimensions in mind: Access, Adoption, Awareness, Affordability. These aren't boxes to tick — they're tensions to navigate. Your fit lives in the space where you've resolved the right tensions for the right stakeholders at the right point in the care journey.
Once you know your fit, the real work begins
Finding your fit isn't the end. It's the beginning of the commercial journey.
Once you know where your technology creates real value, the next step is to understand the market landscape around it. What are the variables at play? What's your competitive advantage? What does the regulatory pathway look like in that modality?
None of that work is worth doing until the fit question is answered honestly. Because the landscape looks completely different depending on where in the patient value chain you're operating and what problem you're actually solving.
That's where we start every conversation at Futuremed. Not with the technology. With the question.